This Article  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Arch Dermatol. 1985;121(1):34.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

New Name. Same Power. Lidex (fluocinonid) x 0.05% y Brief Summary of Prescribing Information LIDEX® (fluocinonide) Gel 0.05% Description: LIDEX gel 0.05% is intended for topical administration. The active component is the corticosteroid fluocinonide, which is the 21-acetate ester of fluocinolone acetonide and has the chemical name pregna-1,4-diene-3,20-dione,21-(acetyloxy)-6,9-difluoro-11 -hydroxy-16,17-[(1-methylethylidene)bis(oxy)]-, (6,11β,16)LIDEX gel contains fluocinonide 0.5 mg/g in a specially formulated gel base consisting of propylene glycol, propyl gallate, edetate disodium, and carbomer 940, with NaOH and/or HCl added to adjust the pH. This clear, colorless thixotropic vehicle is greaseless, non-staining and completely water miscible In this formulation, the active ingredient is totally in solution. Indications: Relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses Contraindications: Hypersensitivity to any ingredient. Precautions General Periodically evaluate patients given a large dose of a potent topical steroid applied to a large area or under occlusive dressing for HPA suppression by using urinary free cortisol and . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?